Recombinant and plasma-purified human c1 inhibitor for the treatment of hereditary angioedema.

World Allergy Organ J · 2010 · PMC3666149 · PMID 23282867

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The results were clear cut: on all of these parameters patients did better on drug, and the results were statistically highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.